Inhibition of STAT3 prevents neointima formation by inhibiting proliferation and promoting apoptosis of neointimal smooth muscle cells.

In cultured vascular smooth muscle cells (SMCs), STAT3 mediates proliferation signal by directly activating transcription of early growth response genes. Recently, we have found that balloon injury transiently induces JAK2 and STAT3 expressions and activations with a peak at day 7 in rat carotid artery. However, the specific role of STAT3 in neointima formation remains unknown. Adenoviral vector encoding a dominant negative STAT3 (AxCAdnSTAT3) or beta-galactosidase (control) was overexpressed in a balloon-injured artery to inhibit endogenous STAT3 activation selectively. In controls, neointima became evident after day 4, and reached a maximum at day 14. The number of bromodeoxyuridine (BrdU)-positive proliferating or TUNEL-positive apoptotic neointimal SMCs peaked at day 7, decreasing to lower levels by day 14. AxCAdnSTAT3 not only abrogated STAT3 phosphorylation but also decreased BrdU labeling index by 60% and increased TUNEL index by 35% at day 7 versus controls, resulting in the 40% reduction in the intima/media area ratio at day 14. At day 7, in controls, vascular injury upregulated antiapoptotic mediator Mcl-i and Bcl-xL expression by 8-fold to 5-fold, respectively, versus sham, whereas proapoptotic Bax slightly increased by 1.5-fold versus sham. AxCAdnSTAT3 reversed the upregulated Mcl-1 and Bcl-xL levels by 70% and 37%,respectively, while having no affect on Bax expression. In conclusion, the STAT3-mediated pathway plays an important role in neointima formation through enhanced vascular SMC accumulation by promoting cell proliferation and survival.

[1]  K. Okumura,et al.  Repeated gene transfer of naked prostacyclin synthase plasmid into skeletal muscles attenuates monocrotaline-induced pulmonary hypertension and prolongs survival in rats. , 2004, Human gene therapy.

[2]  D. Tulis,et al.  Adenoviral Gene Transfer of Fortilin Attenuates Neointima Formation Through Suppression of Vascular Smooth Muscle Cell Proliferation and Migration , 2003, Circulation.

[3]  M. Makuuchi,et al.  Hematopoietic stem cells differentiate into vascular cells that participate in the pathogenesis of atherosclerosis , 2002, Nature Medicine.

[4]  Takafumi Yoshida,et al.  Induction of the cytokine signal regulator SOCS3/CIS3 as a therapeutic strategy for treating inflammatory arthritis. , 2001, The Journal of clinical investigation.

[5]  Y. Kaneda,et al.  Gene Transfer of Dominant-Negative Mutants of Extracellular Signal-Regulated Kinase and c-Jun NH2-Terminal Kinase Prevents Neointimal Formation in Balloon-Injured Rat Artery , 2001, Circulation research.

[6]  R. Jove,et al.  Overexpression of a dominant-negative signal transducer and activator of transcription 3 variant in tumor cells leads to production of soluble factors that induce apoptosis and cell cycle arrest. , 2001, Cancer research.

[7]  M. Makuuchi,et al.  Circulating smooth muscle progenitor cells contribute to atherosclerosis , 2001, Nature Medicine.

[8]  J. Turkson,et al.  Inhibition of STAT3 signaling leads to apoptosis of leukemic large granular lymphocytes and decreased Mcl-1 expression. , 2001, The Journal of clinical investigation.

[9]  M. Morimatsu,et al.  Role of Rho-Associated Kinase in Neointima Formation After Vascular Injury , 2001, Circulation.

[10]  A. Yoshimura,et al.  Role of the JAK/STAT pathway in rat carotid artery remodeling after vascular injury. , 2000, Circulation research.

[11]  J. Darnell,et al.  The role of STATs in transcriptional control and their impact on cellular function , 2000, Oncogene.

[12]  A. Hsueh,et al.  Tissue-specific Bcl-2 protein partners in apoptosis: An ovarian paradigm. , 2000, Physiological reviews.

[13]  J. McEwan,et al.  Expression of tissue inhibitor of matrix metalloproteinases 1 by use of an adenoviral vector inhibits smooth muscle cell migration and reduces neointimal hyperplasia in the rat model of vascular balloon injury. , 1999, Circulation.

[14]  A. Mahfoudi,et al.  Adenovirus-mediated delivery of the Gax transcription factor to rat carotid arteries inhibits smooth muscle proliferation and induces apoptosis , 1999, Gene Therapy.

[15]  G. Gibbons,et al.  Determinants of vascular smooth muscle cell apoptosis after balloon angioplasty injury. Influence of redox state and cell phenotype. , 1999, Circulation research.

[16]  Y. Fujio,et al.  Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. , 1998, Circulation.

[17]  H. Perlman,et al.  Bax‐mediated cell death by the Gax homeoprotein requires mitogen activation but is independent of cell cycle activity , 1998, The EMBO journal.

[18]  Shokei Kim,et al.  Angiotensin blockade inhibits activation of mitogen-activated protein kinases in rat balloon-injured artery. , 1998, Circulation.

[19]  N. Olson,et al.  Cell replication in the arterial wall: activation of signaling pathway following in vivo injury. , 1998, Circulation research.

[20]  Jennifer L Hall,et al.  Inhibition of neointimal cell bcl-x expression induces apoptosis and regression of vascular disease , 1998, Nature Medicine.

[21]  M. Marrero,et al.  Role of Janus Kinase/Signal Transducer and Activator of Transcription and Mitogen-activated Protein Kinase Cascades in Angiotensin II- and Platelet-derived Growth Factor-induced Vascular Smooth Muscle Cell Proliferation* , 1997, The Journal of Biological Chemistry.

[22]  J. Darnell.  STATs and gene regulation. , 1997, Science.

[23]  A. Takeshita,et al.  Adenovirus-mediated transfer of a dominant-negative H-ras suppresses neointimal formation in balloon-injured arteries in vivo. , 1997, Arteriosclerosis, thrombosis, and vascular biology.

[24]  M. Morimatsu,et al.  Inhibition of intimal hyperplasia after balloon injury by antibodies to intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1. , 1997, Circulation.

[25]  J. Díez,et al.  Is the regulation of apoptosis altered in smooth muscle cells of adult spontaneously hypertensive rats? , 1997, Hypertension.

[26]  K Walsh,et al.  Evidence for the rapid onset of apoptosis in medial smooth muscle cells after balloon injury. , 1997, Circulation.

[27]  T. Hirano,et al.  A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells. , 1996, The EMBO journal.

[28]  J. Avruch,et al.  Stress-activated protein kinases in cardiovascular disease. , 1996, Circulation research.

[29]  Y. Kanegae,et al.  Efficient generation of recombinant adenoviruses using adenovirus DNA-terminal protein complex and a cosmid bearing the full-length virus genome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  M. Marrero,et al.  The role of tyrosine phosphorylation in angiotensin II mediated intracellular signaling and cell growth , 1996, Journal of Molecular Medicine.

[31]  A. Takeshita,et al.  Quantitative analysis of repeat adenovirus-mediated gene transfer into injured canine femoral arteries. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[32]  M. Leon,et al.  Evidence for apoptosis in human atherogenesis and in a rat vascular injury model. , 1995, The American journal of pathology.

[33]  S. Schwartz,et al.  Assessment of Factors Important in Atherosclerotic Occlusion and Restenosis , 1995, Thrombosis and Haemostasis.

[34]  J. Isner,et al.  Apoptosis in human atherosclerosis and restenosis. , 1995, Circulation.

[35]  B. Berk,et al.  Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor , 1995, Nature.

[36]  P. Coffer,et al.  Transcriptional regulation of the junB promoter: analysis of STAT-mediated signal transduction. , 1995, Oncogene.

[37]  G. J. Bhat,et al.  Angiotensin II stimulates sis-inducing factor-like DNA binding activity. Evidence that the AT1A receptor activates transcription factor-Stat91 and/or a related protein. , 1994, The Journal of biological chemistry.

[38]  Z. Oltvai,et al.  Checkpoints of dueling dimers foil death wishes , 1994, Cell.

[39]  R. Alexander,et al.  Agonist-induced phosphorylation of the vascular type 1 angiotensin II receptor. , 1994, Hypertension.

[40]  J. Darnell,et al.  Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. , 1994, Science.

[41]  R. Crystal,et al.  Efficient and Selective Adenovirus‐Mediated Gene Transfer Into Vascular Neointima , 1993, Circulation.

[42]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[43]  D Schwartz,et al.  A Cascade Model for Restenosis: A Special Case of Atherosclerosis Progression , 1992, Circulation.

[44]  E J Topol,et al.  The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. , 1992, Journal of the American College of Cardiology.

[45]  G. Montalescot,et al.  Myocardial Viability in Patients With Q Wave Myocardial Infarction and No Residual Ischemia , 1992, Circulation.

[46]  M. Reidy,et al.  Kinetics of cellular proliferation after arterial injury. I. Smooth muscle growth in the absence of endothelium. , 1983, Laboratory investigation; a journal of technical methods and pathology.

[47]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[48]  Ankoor S. Shah,et al.  Prolonged exposure to agonist results in a reduction in the levels of the Gq/G11 alpha subunits in cultured vascular smooth muscle cells. , 1996, Molecular pharmacology.

[49]  N. Reich,et al.  Signal transduction and activation of gene transcription by interferons. , 1995, Gene expression.